Quest Reconciled Depreciation from 2010 to 2025

DGX Stock  USD 175.41  1.35  0.78%   
Quest Diagnostics Reconciled Depreciation yearly trend continues to be fairly stable with very little volatility. Reconciled Depreciation will likely drop to about 419.8 M in 2025. During the period from 2010 to 2025, Quest Diagnostics Reconciled Depreciation regression line of annual values had r-squared of  0.81 and arithmetic mean of  335,174,219. View All Fundamentals
 
Reconciled Depreciation  
First Reported
1996-09-30
Previous Quarter
125 M
Current Value
135 M
Quarterly Volatility
28.3 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 274.7 M, Interest Expense of 237.3 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0208 or PTB Ratio of 2.99. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Quest Diagnostics Correlation against competitors.

Latest Quest Diagnostics' Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of Quest Diagnostics Incorporated over the last few years. It is Quest Diagnostics' Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quest Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

Quest Reconciled Depreciation Regression Statistics

Arithmetic Mean335,174,219
Geometric Mean326,960,498
Coefficient Of Variation23.79
Mean Deviation69,217,773
Median309,000,000
Standard Deviation79,747,282
Sample Variance6359.6T
Range223M
R-Value0.90
Mean Square Error1326.2T
R-Squared0.81
Slope15,032,077
Total Sum of Squares95394.4T

Quest Reconciled Depreciation History

2025419.8 M
2024493 M
2023446 M
2022437 M
2021408 M
2020361 M
2019329 M

About Quest Diagnostics Financial Statements

Quest Diagnostics investors use historical fundamental indicators, such as Quest Diagnostics' Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Reconciled Depreciation493 M419.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.